Stopped: Trial futility
Lung resections for pulmonary malignancies offer the best chance of survival for patients, but these procedures carry a significant burden of post-operative morbidity and mortality. Patients are particularly at high risk for post-operative atrial fibrillation (a condition involving irregular heart rhythm). Atrial fibrillation with symptoms can increase the risk of stroke - a blockage in a major blood vessel in the brain, which can potentially result in a disability or even death. The objective of this study is to establish the feasibility of using ambulatory heart rate monitoring to determine the total incidence of atrial fibrillation in the peri-operative period before and after anatomic lung resection for malignancies. The study will also investigate the correlation between atrial fibrillation and rates of stroke and other adverse events, as well as serve to identify the patients that are at a higher risk of developing atrial fibrillation.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Monthly rate of patient accrual
Timeframe: Ongoing from date of study initiation through to sample size completion, estimated to be 12 months
Patient adherence to monitoring device use-Wear time
Timeframe: 28 day time period around lung resection
Patient adherence to monitoring device use-Logging of symptomatic events
Timeframe: 28 day time period around lung resection
Number of patients who withdraw from study protocol
Timeframe: 28 day time period around lung resection